Real Estate Articles

Boston Herald

Merck: FDA reviewing its ragweed allergy therapy

May 8, 2013

WHITEHOUSE STATION, N.J. ? Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.

Merck's latest application is for an allergy immunotherapy tablet for ragweed allergies that dissolves under the tongue. Patients in studies of the tablet took it daily for a year.

Read entire article on Boston Herald
« Previous Article Next Article »

More From Real Estate Articles

  • Bank of America, MBIA settle dispute: WSJ
  • Reese Witherspoon Buys House Next Door
  • Monday Mish Mash: L.A. Reid
  • Write a Story/Review about this topic

    Post a Comment

     

    Best of Luxury

    Finding the best in luxury can be a daunting task, which is why we've taken it on for you.
    View All Best of Luxury
    THINGS WE LIKE